AL
Altimmune
ALT·NASDAQGaithersburg MDFounded 200580 employees
Small CapbiotechPublicMetabolic
Platform: GLP-1/GCG
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ALT)
Loading ALT stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gozeosocimab | ALT-658 | Preclinical | 2 | B7-H3 | SLECLL | ||
| Elratuximab | ALT-4728 | Phase 3 | 1 | BCMA | Cervical Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)